{
    "Trade/Device Name(s)": [
        "QIAstat-Dx Respiratory Panel Mini"
    ],
    "Submitter Information": "QIAGEN GmbH",
    "510(k) Number": "K242353",
    "Predicate Device Reference 510(k) Number(s)": [
        "K233100"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QOF"
    ],
    "Summary Letter Date": "August 7, 2024",
    "Summary Letter Received Date": "August 8, 2024",
    "Submission Date": "October 11, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3981"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Identify Nucleic Acid Targets In Respiratory Specimens From Microbial Agents That Cause The SARS-CoV-2 Respiratory Infection And Other Microbial Agents When In A Multi-Target Test"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A",
        "Influenza B",
        "Respiratory Syncytial Virus",
        "Human Rhinovirus",
        "SARS-CoV-2"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal swabs (NPS)"
    ],
    "Specimen Container(s)": [
        "Universal Transport Media (UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "QIAstat-Dx Analyzer 1.0",
        "QIAstat-Dx system"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex real-time RT-PCR",
        "Membrane-based nucleic acid purification"
    ],
    "Methodologies": [
        "Real-time RT-PCR",
        "Multiplex nucleic acid testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Cartridge",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for QIAstat-Dx Respiratory Panel Mini multiplex RT-PCR assay for qualitative detection of five respiratory viruses using nasopharyngeal swabs",
    "Indications for Use Summary": "Multiplexed nucleic acid test for qualitative detection and identification of Influenza A, Influenza B, Respiratory Syncytial Virus, Human Rhinovirus, and SARS-CoV-2 in nasopharyngeal swabs from individuals with signs and symptoms of respiratory infection, to aid in diagnosis in conjunction with other clinical findings.",
    "fda_folder": "Microbiology"
}